Frystyk J - Search Results

1

Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist.

Jørgensen JO, Feldt-Rasmussen U, Frystyk J, Chen JW, Kristensen LØ, Hagen C, Ørskov H. Jørgensen JO, et al. Among authors: frystyk j. J Clin Endocrinol Metab. 2005 Oct;90(10):5627-31. doi: 10.1210/jc.2005-0531. Epub 2005 Jul 26. J Clin Endocrinol Metab. 2005. PMID: 16046586 Clinical Trial.

2

Insulin-like growth factor I in initial renal hypertrophy in potassium-depleted rats.

Flyvbjerg A, Marshall SM, Frystyk J, Rasch R, Bornfeldt KE, Arnqvist H, Jensen PK, Pallesen G, Orskov H. Flyvbjerg A, et al. Among authors: frystyk j. Am J Physiol. 1992 Jun;262(6 Pt 2):F1023-31. doi: 10.1152/ajprenal.1992.262.6.F1023. Am J Physiol. 1992. PMID: 1377873

3

Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion.

Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Orskov H. Flyvbjerg A, et al. Among authors: frystyk j. Kidney Int. 1992 Apr;41(4):805-12. doi: 10.1038/ki.1992.124. Kidney Int. 1992. PMID: 1513103 Free article.

4

Octreotide and diabetes: theoretical and experimental aspects.

Orskov H, Flyvbjerg A, Frystyk J, Ledet T, Møller N, Christensen SE, Harris AG. Orskov H, et al. Among authors: frystyk j. Metabolism. 1992 Sep;41(9 Suppl 2):66-71. doi: 10.1016/0026-0495(92)90034-8. Metabolism. 1992. PMID: 1518436 Review.

5

Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats.

Flyvbjerg A, Frystyk J, Osterby R, Orskov H. Flyvbjerg A, et al. Among authors: frystyk j. Am J Physiol. 1992 Jun;262(6 Pt 1):E956-62. doi: 10.1152/ajpendo.1992.262.6.E956. Am J Physiol. 1992. PMID: 1616029

6

Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat.

Marshall SM, Flyvbjerg A, Frystyk J, Korsgaard L, Orskov H. Marshall SM, et al. Among authors: frystyk j. Diabetologia. 1991 Sep;34(9):632-9. doi: 10.1007/BF00400992. Diabetologia. 1991. PMID: 1659546

7

Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats.

Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Orskov H. Flyvbjerg A, et al. Among authors: frystyk j. Diabetologia. 1989 Apr;32(4):261-5. doi: 10.1007/BF00285295. Diabetologia. 1989. PMID: 2759363

8

Free insulin-like growth factors in human obesity.

Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Frystyk J, et al. Metabolism. 1995 Oct;44(10 Suppl 4):37-44. doi: 10.1016/0026-0495(95)90219-8. Metabolism. 1995. PMID: 7476310

9

Effect of octreotide on experimental diabetic renal and glomerular growth: importance of early intervention.

Grønbaek H, Nielsen B, Frystyk J, Orskov H, Flyvbjerg A. Grønbaek H, et al. Among authors: frystyk j. J Endocrinol. 1995 Oct;147(1):95-102. doi: 10.1677/joe.0.1470095. J Endocrinol. 1995. PMID: 7490542

10

Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.

Møller J, Jørgensen JO, Lauersen T, Frystyk J, Naeraa RW, Orskov H, Christiansen JS. Møller J, et al. Among authors: frystyk j. Clin Endocrinol (Oxf). 1993 Oct;39(4):403-8. doi: 10.1111/j.1365-2265.1993.tb02386.x. Clin Endocrinol (Oxf). 1993. PMID: 7507009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters